Analgesic, anti-inflammatory, and antimicrobial activities of novel isoxazole/pyrimidine/pyrazole substituted benzimidazole analogs
- 235 Downloads
From o-phenylenediamine and p-amino benzoic acid, several new 3-methylisoxazol-5(4H)-one/2-hydroxy/mercapto-6-methylpyrimidin-4(5H)-one/3-methyl-1-substituted-1H-pyrazol-5(4H)-one substituted benzimidazole derivatives 5–16 were synthesized through multi step synthesis based on hybrid approach. All test compounds were screened for its analgesic, anti-inflammatory, and in vitro antimicrobial activity by tail flick method, carrageenan induced foot paw edema method and agar streak dilution method, respectively. Most active compounds were examined for its ulcerogenicity by pylorus ligation method. The relationship between chemical structure and biological activities of the test compounds were discussed. Among various tested compounds, 4-(2-(4-(1H-benzimidazol-2-yl)phenyl)hydrazono)-1-(4-chlorophenyl)-3-methyl-1H-pyrazol-5(4H)-one 10 was found to be most potent compound. This compound showed 72% analgesic activity (20 mg/kg; second hour) and 67% protection in paw edema test (20 mg/kg; second hour) which are comparable with that of standard Diclofenac [69% analgesic activity (20 mg/kg; second hour) and 65% protection in paw edema test (20 mg/kg; second hour)]. In addition, compound 10 exhibited least ulcer index which is about 1/3 of the ulcer index of reference standard and showed good antibacterial and moderate antifungal activity.
KeywordsBenzimidazole Isoxazole Pyrimidine Analgesic Anti-inflammatory Antimicrobial
The authors gratefully acknowledge the management of Sarojini Naidu Vanita Pharmacy Maha Vidyalaya, Secunderabad, for providing infrastructure facilities to carry out this research work.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- Avinash P, Swastika G, Sanjay S (2008) A systematic review of benzimidazole derivatives as an antiulcer agent. Rasayan J Chem 1:447–460Google Scholar
- D’Amour FE, Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74–79Google Scholar
- Dhikav V, Singh S, Pande S, Chawla A, Anand KS (2003) Non steroidal drug induced gastrointestinal toxicity: Mechanisms and management. J Indian Acad Clin Med 4:315–322Google Scholar
- Feldman B, Zinkl J, Jain N (2000) Veterinary hematology. Lippincott Williams and Wilkins, Philadelphia, p 213Google Scholar
- Govindaraj S, Veerachamy A, Pandurangan D (2013) Synthesis, analgesic, anti-inflammatory and in vitro antimicrobial activities of some novel isoxazole coupled quinazolin-4(3H)- one derivatives. Arch Pharm Res doi: 10.1007/s12272-013-0262-8
- Hawkey PM, Lewis DA (1994) Medical bacteriology—a practical approach. Oxford University Press, Oxford, p 181–194Google Scholar
- Olfert ED, Cross BM, McWilliam AA (1993) Guide to the care and use of experimental animals, vol 1, 2nd edn. Canadian council of animal care, Canada, p 1–201Google Scholar
- Panneer Selvam T, Saravanan G, Prakash CR, Dinesh Kumar P (2011) Microwave assisted synthesis, characterization and biological activity of novel pyrazole derivatives. Asian J Pharm Res 1:126–129Google Scholar
- Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM, Rogers RS, Rogier DJ, Yu SS, Anderson GD, Burton EG, Cogburn JN, Gregory SA, Koboldt CM, Perkins WE, Seibert K, Veenhuizen AW, Zhang YY, Isakson PC (1997) Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methyl phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, celecoxib). J Med Chem 40:1347–1365CrossRefPubMedPubMedCentralGoogle Scholar
- Shay M, Komarov SA, Fels D, Meranze D, Grunstein H, Siplet H (1945) A simple method for the uniform production of gastric ulceration in the rats. Gastroenterology 5:43–61Google Scholar
- Trepanier LA (2002) Mechanisms of drug associated hepatotoxicity in the dog and cat. In: Proceedings on 20th Annual Forum of the ACVIM. Dallas 669–671Google Scholar